Margaret Taylor

1.6k total citations
25 papers, 1.3k citations indexed

About

Margaret Taylor is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Margaret Taylor has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Immunology. Recurrent topics in Margaret Taylor's work include Influenza Virus Research Studies (4 papers), Advanced Breast Cancer Therapies (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Margaret Taylor is often cited by papers focused on Influenza Virus Research Studies (4 papers), Advanced Breast Cancer Therapies (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Margaret Taylor collaborates with scholars based in United States, United Kingdom and Canada. Margaret Taylor's co-authors include Amarnath Natarajan, Yogesh A. Sonawane, Andrew W. Bruce, Gregor Reid, Sandeep Rana, Jacob I. Contreras, G.L. Taylor, Aaron M. Mohs, Tanner K. Hill and Denis Svechkarev and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Margaret Taylor

25 papers receiving 1.3k citations

Peers

Margaret Taylor
Ruian Xu China
Dong Wook Choi South Korea
Carl I. Webster United Kingdom
Chris Barton United Kingdom
Byung H. Jhun South Korea
Jeff Zhiqiang Lu United States
Ruian Xu China
Margaret Taylor
Citations per year, relative to Margaret Taylor Margaret Taylor (= 1×) peers Ruian Xu

Countries citing papers authored by Margaret Taylor

Since Specialization
Citations

This map shows the geographic impact of Margaret Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret Taylor more than expected).

Fields of papers citing papers by Margaret Taylor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret Taylor. The network helps show where Margaret Taylor may publish in the future.

Co-authorship network of co-authors of Margaret Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret Taylor. A scholar is included among the top collaborators of Margaret Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret Taylor. Margaret Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Robb, Caroline M., Smit Kour, Jacob I. Contreras, et al.. (2020). Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 11(25). 2462–2463. 3 indexed citations
2.
Rana, Sandeep, Yogesh A. Sonawane, Margaret Taylor, et al.. (2018). Synthesis of aminopyrazole analogs and their evaluation as CDK inhibitors for cancer therapy. Bioorganic & Medicinal Chemistry Letters. 28(23-24). 3736–3740. 18 indexed citations
3.
Robb, Caroline M., Jacob I. Contreras, Smit Kour, et al.. (2017). Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC). Chemical Communications. 53(54). 7577–7580. 177 indexed citations
4.
Bhattacharya, Deep, Denis Svechkarev, Joshua J. Souchek, et al.. (2017). Impact of structurally modifying hyaluronic acid on CD44 interaction. Journal of Materials Chemistry B. 5(41). 8183–8192. 156 indexed citations
5.
Robb, Caroline M., Smit Kour, Jacob I. Contreras, et al.. (2017). Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 9(4). 5216–5232. 25 indexed citations
6.
Pitmon, Elise, et al.. (2016). The D1 family dopamine receptor, DopR, potentiates hind leg grooming behavior in Drosophila. Genes Brain & Behavior. 15(3). 327–334. 21 indexed citations
7.
Sonawane, Yogesh A., et al.. (2016). Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy. Journal of Medicinal Chemistry. 59(19). 8667–8684. 124 indexed citations
8.
Connaris, Helen, Elena A. Govorkova, Bernadette M. Dutia, et al.. (2014). Prevention of influenza by targeting host receptors using engineered proteins. Proceedings of the National Academy of Sciences. 111(17). 6401–6406. 36 indexed citations
9.
Kerry, Philip S., Juan Ayllón, Margaret Taylor, et al.. (2011). A Transient Homotypic Interaction Model for the Influenza A Virus NS1 Protein Effector Domain. PLoS ONE. 6(3). e17946–e17946. 44 indexed citations
10.
Kerry, Philip S., et al.. (2011). Conservation of a crystallographic interface suggests a role for β-sheet augmentation in influenza virus NS1 multifunctionality. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 67(8). 858–861. 10 indexed citations
11.
Ren, Yimin, Hongwei Xu, Fleur Davey, et al.. (2008). Endophilin I Expression Is Increased in the Brains of Alzheimer Disease Patients. Journal of Biological Chemistry. 283(9). 5685–5691. 52 indexed citations
12.
Cole, Adam R., Wendy Noble, Florian Plattner, et al.. (2007). Collapsin response mediator protein‐2 hyperphosphorylation is an early event in Alzheimer’s disease progression. Journal of Neurochemistry. 103(3). 1132–1144. 150 indexed citations
13.
Yao, Jun, Margaret Taylor, Fleur Davey, et al.. (2007). Interaction of amyloid binding alcohol dehydrogenase/Aβ mediates up-regulation of peroxiredoxin II in the brains of Alzheimer’s disease patients and a transgenic Alzheimer’s disease mouse model. Molecular and Cellular Neuroscience. 35(2). 377–382. 70 indexed citations
14.
Janik, John E., John C. Morris, Wendy Gao, et al.. (2005). Phase I Trial of Siplizumab in CD2-Positive Lymphoproliferative Disease. Journal of Immunotherapy. 28(6). 644–644. 10 indexed citations
15.
Moustafa, Ibrahim M., Helen Connaris, Margaret Taylor, et al.. (2004). Sialic Acid Recognition by Vibrio cholerae Neuraminidase. Journal of Biological Chemistry. 279(39). 40819–40826. 126 indexed citations
16.
Newstead, Simon, et al.. (2004). Crystallization and atomic resolution X-ray diffraction of the catalytic domain of the large sialidase, nanI, fromClostridium perfringens. Acta Crystallographica Section D Biological Crystallography. 60(11). 2063–2066. 10 indexed citations
17.
Goudie, Andrew J., et al.. (1998). Discriminative stimulus properties of the atypical neuroleptic clozapine in rats: tests with subtype selective receptor ligands. Behavioural Pharmacology. 9(8). 699–710. 45 indexed citations
18.
Goss, Glenwood, et al.. (1995). Didemnin B in favourable histology non-Hodgkin's lymphoma. Investigational New Drugs. 13(3). 257–260. 9 indexed citations
19.
Reid, Gregor, Andrew W. Bruce, & Margaret Taylor. (1992). Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections.. PubMed. 14(1). 11–6. 105 indexed citations
20.
Heyer, Ken den, et al.. (1986). On the nature of neutral primes in a lexical decision task. Psychological Research. 48(3). 161–168. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026